Aclaris Therapeutics Inc News - ACRS | ADVFN

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Aclaris Therapeutics Inc (ACRS)
Aclaris Therapeutics Inc (ACRS) News

Aclaris Therapeutics Inc (ACRS)

1.20

0.00

(0.00%)

Closed April 29 4:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

Form 8-K - Current report

Form 8-K - Current report

Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review

- Douglas Manion, M.D. to step down as Chief Executive Officer, President and Member of Board of Directors...

Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis

- ATI-1777 2% BID Achieved a Statistically Significant Result in the Primary Efficacy Endpoint at Week 4...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Aclaris Therapeutics Provides Corporate Update

- ATI-1777 Phase 2a Trial Results Published in JID Innovations -- ATI-1777 Phase 2b Trial Topline Data...

Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia

WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage...

Form 8-K - Current report

Aclaris Therapeutics Announces Top-line Results from 12-Week Phase 2b Trial of Oral Zunsemetinib (ATI-450) for Moderate to Severe Rheumatoid Arthritis and Provides Corporate Update

— Study Did Not Meet Primary or Secondary Efficacy Endpoints in Rheumatoid Arthritis — — Efficacy Results Do...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

- Topline Data from Zunsemetinib Phase 2b Trial in Rheumatoid Arthritis Expected this Month – - Completion of...

Form 4 - Statement of changes in beneficial ownership of securities

Monksdream

Monksdream 4 weeks ago

glenn1919

glenn1919 2 months ago

ACRS..........................................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783

Triple nickle

Triple nickle 4 months ago

No worries here still adding.

TheFinalCD

TheFinalCD 5 months ago

ACRS The agreement includes an upfront payment of $15 million, regulatory and commercial milestones, and royalties

81vette

81vette 5 months ago

7.4M short,1.5M available to short,fee 1%,rebate is 4.5% holy crap they pay you to short it,no wonder it’s shorted so much and beaten down,squeeze could be huge

81vette

81vette 5 months ago

Could be interesting,beaten down,definitely run room

TheFinalCD

TheFinalCD 5 months ago

ACRS NEWS https://www.globenewswire.com/news-release/2023/12/05/2791335/37216/en/Aclaris-Therapeutics-Announces-Patent-License-Agreement-with-Sun-Pharma-for-Alopecia.html

https://finviz.com/quote.ashx?t=ACRS&p=d

https://dilutiontracker.com/app/search/ACRS

https://finance.yahoo.com/news/aclaris-acrs-loses-83-17-143502790.html

Terpi

Terpi 5 months ago

Zorro

Zorro 6 months ago

Way overdone. Shorter's paradise. Lol!

Penny chatter

Penny chatter 6 months ago

Afterhoursearnings3

Afterhoursearnings3 6 months ago

Grabbed some here on the overreaction

TimeFades

TimeFades 6 months ago

TheFinalCD

TheFinalCD 6 months ago

ACRS.67 Aclaris Therapeutics to stop development of rheumatoid arthritis drug

https://finviz.com/quote.ashx?t=ACRS&ty=c&ta=1&p=d

https://dilutiontracker.com/app/search/ACRS?a=dbb88c

alchemytrader

alchemytrader 3 years ago

I was short premarket 20.30 then quickly covered 20.27 for scratch because she was still holding up.

Shes a scary on to short. ran to 24.00 at open before fading.

In hindsight, should have shorted 24.00 but was busy with other plays.

SteevoTrader

SteevoTrader 3 years ago

ACRS offering more than 5m shares at $17.50/per share

alchemytrader

alchemytrader 3 years ago

The way she kept grinding back to 19s could gap.

Who knows in this market. Robin Hood traders buy anything.

SteevoTrader

SteevoTrader 3 years ago

Are we seeing a dump tomorrow?

alchemytrader

alchemytrader 3 years ago

Oh really? hit 19.95 today...

ClayTrader

ClayTrader 3 years ago

* * $ACRS Video Chart 01-19-2021 * *

Link to Video - click here to watch the technical chart video

Marketwise

Marketwise 3 years ago

One month later. Take a look now. E-trade certainly did you no favor.

Docstemcell2020

Docstemcell2020 3 years ago

Serge521

Serge521 3 years ago

Im so happy Etrade wouldnt let me buy this couple of days ago..
I owe Etrade big

interloper

interloper 4 years ago

So ACRS trials will take 2 years but let’s rush a vaccine out by January 2021.

DanSanTrades

DanSanTrades 4 years ago

ACRS Trials gets an update from the FDA. Their now recruiting for the trial. Status updated over the weekend.

Clinical Trial Link

ClayTrader

ClayTrader 4 years ago

* * $ACRS Video Chart 07-20-2020 * *

Link to Video - click here to watch the technical chart video

ClayTrader

ClayTrader 4 years ago

* * $ACRS Video Chart 06-17-2020 * *

Link to Video - click here to watch the technical chart video

ClayTrader

ClayTrader 4 years ago

* * $ACRS Video Chart 01-10-2020 * *

Link to Video - click here to watch the technical chart video

beambe

beambe 4 years ago

XenaLives

XenaLives 4 years ago

Just a shout out here, anyone with fundamental DD on ACRS?

jonny_red

jonny_red 4 years ago

3 Penny Stocks To Watch As Biotech Hits New Highs

$ACRS $ISEE $ONCY

https://www.transparenttraders.me/2019/10/3-penny-stocks-to-watch-as-biotech-hits.html

ClayTrader

ClayTrader 4 years ago

* * $ACRS Video Chart 10-29-2019 * *

Link to Video - click here to watch the technical chart video

BottomBounce

BottomBounce 4 years ago

$ACRS Overbought Aclaris Therapeutics (ACRS) May Report Negative Earnings

jonny_red

jonny_red 5 years ago

3 Best Penny Stocks To Trade Before Next Week?

$ATNM $CHK $ACRS

https://www.transparenttraders.me/2019/10/3-best-penny-stocks-to-trade-before.html

VMB-1

VMB-1 5 years ago

~2.00+ SQUUUUEEEEEZEEE

VMB-1

VMB-1 5 years ago

~in @1.83...Gonna Spike new HOD..

dndodd

dndodd 5 years ago

the shorts will have to cover over 4mm last report up significantly but they will play games for sure.

Neverland66

Neverland66 5 years ago

Sold 1/3 of shares in after market @ $2.08. Bought back this morning @ $1.88.

NOW LET 'EM RUN!

This, coupled with the news from 2 weeks ago, should send this north a considerable way. May take a few days, but $3?

toybaby

toybaby 5 years ago

VMB-1

VMB-1 5 years ago

~Buy AfterHours for another Halt Spike AM 2morrow?

stock1ace1

stock1ace1 5 years ago

Positive phase 3 news just out !

stock1ace1

stock1ace1 5 years ago

ClayTrader

ClayTrader 5 years ago

* * $ACRS Video Chart 10-22-2019 * *

Link to Video - click here to watch the technical chart video

toybaby

toybaby 5 years ago

AugustaFriends

AugustaFriends 5 years ago

We should see $2.08 as next resistance

stock1ace1

stock1ace1 5 years ago

toybaby

toybaby 5 years ago

ADVFN_bioking

ADVFN_bioking 5 years ago

Arkin Moshe discloses 8.02% activist ownership in ACRS / Aclaris Therapeutics, Inc.

October 15, 2019 - Arkin Moshe has filed an SC 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,319,750 shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS). This represents 8.02 percent ownership of the company.

toybaby

toybaby 5 years ago

toybaby

toybaby 5 years ago

I still do things like that I sold a sizable amount at 1.11 and BOUGHT THEM BACK AT 1.15 GO Figure

stock1ace1

stock1ace1 5 years ago

A novice trader sold pm @1.25 im dead :) lmfao

Aclaris Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions